title: Plasma miR-208 as a useful biomarker for drug-induced cardiotoxicity in rats.
abstract: Cardiotoxicity is one of the major safety concerns in drug development. Therefore, detecting and monitoring cardiotoxicity throughout preclinical and clinical studies is important for pharmaceutical companies. The present study was conducted in order to explore a plasma miRNA biomarker for cardiotoxicity in rats. As organ specificity is an important factor for a biomarker, we analyzed the miRNA microarray dataset in 55 organs/tissues in normal male rats. Based on this analysis, 5 miRNAs consisting of miR-208 (heart-specific), miR-1, miR-133a, miR-133b (heart and skeletal muscle-specific) and miR-206 (skeletal muscle-specific) were selected. Next, we evaluated the usefulness of those 5 miRNAs as circulating biomarkers in rats administered with single-dose isoproterenol or doxorubicin. Plasma miR-208 was consistently increased through 24 h after dosing in rats administered with isoproterenol, whereas plasma concentrations of cardiac troponin (cTn) showed transient elevation. In contrast, the plasma levels of miR-1, miR-133a, miR-133a and miR-206 were elevated after treatment with doxorubicin, probably as a result of skeletal muscle toxicity. Additionally, the plasma miR-208 level was elevated even after repeat-dose administration (once daily for 7 days) of isoproterenol under which the pathological condition proceeded to the sub-chronic phase such as fibrosis. Thus, our data suggest that miR-208 is a promising plasma biomarker for cardiotoxicity in rats. Monitoring of plasma miR-208 levels in rats may lead to more accurate evaluation of cardiotoxicity in preclinical studies.
authors.affiliation: Research Laboratory for Development, Shionogi & Co., Ltd., 3-1-1 Futaba-cho, Toyonaka, Osaka, 561-0825, Japan.
authors.forename: Yoko
authors.initials: Y
authors.lastname: Nishimura
authors.forename: Chiaki
authors.initials: C
authors.lastname: Kondo
authors.forename: Yuji
authors.initials: Y
authors.lastname: Morikawa
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Tonomura
authors.forename: Mikinori
authors.initials: M
authors.lastname: Torii
authors.forename: Jyoji
authors.initials: J
authors.lastname: Yamate
authors.forename: Takeki
authors.initials: T
authors.lastname: Uehara
mesh_terms: D000818:Animals; D015415:Biomarkers / Q000097:blood; D066126:Cardiotoxicity / Q000097:blood* / Q000209:etiology / Q000473:pathology; D004317:Doxorubicin / Q000633:toxicity; D006321:Heart / Q000187:drug effects; D007545:Isoproterenol / Q000633:toxicity; D008297:Male; D035683:MicroRNAs / Q000097:blood*; D018482:Muscle, Skeletal / Q000187:drug effects / Q000473:pathology; D009206:Myocardium / Q000473:pathology; D020411:Oligonucleotide Array Sequence Analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D060888:Real-Time Polymerase Chain Reaction; D014336:Troponin / Q000097:blood
chemical_list: D015415:Biomarkers; C569395:MIRN208 microRNA, rat; D035683:MicroRNAs; D014336:Troponin; D004317:Doxorubicin; D007545:Isoproterenol
keywords: biomarker; cardiotoxicity; miR-208; miRNA; troponin